Lamotrigina Accord

Lamotrigine, the active ingredient in Lamotrigina Accord, is a sodium channel blocker presented as oral tablets for oral use. It treats epilepsy, including partial and generalized tonic‑clonic seizures, and is used as maintenance therapy for bipolar disorder in adults. GNH USA supplies Lamotrigina Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine acts on neuronal sodium channels to control seizure activity and mood stabilization. - Partial seizures: reduces frequency of focal seizures. - Generalized tonic‑clonic seizures: lowers occurrence of convulsive episodes. - Bipolar disorder (maintenance): helps maintain mood stability and prevents relapse.

Lamotrigine may cause a range of adverse reactions.

Common Side Effects: - Dizziness - Headache - Nausea - Rash (mild) - Blurred vision - Fatigue

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe skin reactions (e.g., drug reaction with eosinophilia and systemic symptoms) - Blood dyscrasias such as agranulocytosis - Hepatic failure - Suicidal thoughts or behavior - Severe hypersensitivity reactions

Lamotrigine requires careful monitoring and patient education. - Monitor serum levels: adjust dose when interacting medications are added or removed. - Assess hepatic function: lamotrigine is metabolised in the liver and may need adjustment in impairment. - Avoid abrupt discontinuation: sudden stop can precipitate seizure recurrence. - Use caution in pregnancy: classified as Category C; discuss potential risks with a healthcare professional. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Lamotrigine interacts with several drugs that can alter its plasma concentration.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine levels, risk of toxicity. - Carbamazepine: reduces lamotrigine concentrations, may diminish efficacy. - Phenytoin: lowers lamotrigine exposure, requiring dose adjustment. - Oral contraceptives: increase lamotrigine levels, may need monitoring.

Moderate Interactions (Monitor Closely): - Other enzyme‑inducing antiepileptics (e.g., phenobarbital): may decrease lamotrigine levels. - Serotonergic agents: potential for additive central nervous system effects. - NSAIDs: may increase risk of rash when combined with lamotrigine.